间充质干细胞
炎症
肿瘤坏死因子α
成纤维细胞
关节炎
先天性淋巴细胞
癌症研究
成纤维细胞活化蛋白
生物
细胞生物学
免疫学
先天免疫系统
免疫系统
细胞培养
遗传学
癌症
作者
Simon Rauber,Hashem Mohammadian,Christian Schmidkonz,Armin Atzinger,Alina Soare,Christoph Treutlein,Samuel Kemble,Christopher B. Mahony,Manuel Geisthoff,Mario Raphael Angeli,Maria Gabriella Raimondo,Cong Xu,Kai‐Ting Yang,Le Lu,Hannah Labinsky,Mina Saad Aziz Saad,Charles Gwellem Anchang,Jiyang Chang,Kaiyue Huang,Eleni I. Kampylafka
标识
DOI:10.1038/s41590-024-01774-4
摘要
Abstract Fibroblasts are key orchestrators of inflammation. Little is known whether these cells change phenotype during resolution of inflammation. We adopted a method to visualise fibroblast activation during inflammation in humans in vivo, which is based on a fibroblast activation protein (FAP) tracer detected by positron emission tomography (PET). While tracer accumulation was high in active arthritis, it decreased significantly after TNF- and IL-17A inhibition. Biopsy-based scRNA-seq analyses in experimental arthritis demonstrated that FAP signal reduction reflected a phenotypic switch from pro-inflammatory MMP3+/IL6+ fibroblasts (high FAP internalisation) to pro-resolving CD200+DKK3+ fibroblasts (low FAP internalisation). Spatial transcriptomics of human joints revealed that pro-resolving niches of CD200+DKK3+ fibroblasts clustered with innate lymphoid cells (ILC)2, whereas MMP3+/IL6+ fibroblasts were co-localised with inflammatory immune cells. CD200+DKK3+ fibroblasts stabilised the ILC2 phenotype and induced resolution of arthritis via CD200/CD200R1 pathway. Taken together, these data suggest a dynamic molecular regulation of the mesenchymal compartment during resolution of inflammation.
科研通智能强力驱动
Strongly Powered by AbleSci AI